Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
GSKJ1 is a selective and potent histone demethylase inhibitor (GSK-J1) that has significant activity (IC50 60 nM for human JmjD3) in vitro and in cells using an ester derivative (GSK-J4: 1 µM < IC50 < 10 µM
PubMed PMID: 24598368
Smiles: NNC(=O)C1C=CN=CC=1
Zanamivir blocks the action of neuraminidase
It effectively inhibits proliferation of most cell lines in the NCI 60 human cancer panel
Captopril eptomycin sulfate GSKJ1 is a selective andCaptopril is an angiotensin converting enzyme (ACE) inhibitor used for the treatment of hypertension and some types of congestive heart failure. Captopril was the first ACE inhibitor developed and was considered a breakthrough both because of its novel mechanism of action and also because of the revolutionary development process. Captopril was discovered and developed at Squibb and Sons Pharmaceuticals based on concepts pioneered by Nobel Laureate
US$ 1732.50
US$ 161.50